Point72 Middle East FZE’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,260	Closed	-$73.9K	–	70
2023 Q4	$73.9K	Buy	3,260 +7	+0.2%	+$159	﹤0.01%	708
2023 Q3	$60.6K	Buy	+3,253	New	+$60.6K	﹤0.01%	711